Skip to main content
. 2019 Jan 29;10:71. doi: 10.3389/fimmu.2019.00071

Table 4.

Univariate and multivariate cox regression analyses of clinicopathological parameters and TIL in validation cohort.

Clinicopathological parameters Univariate analysis Multivariate analysis
HR 95% CI P-value HR 95% CI P-value
Gender (male/female) 0.716 0.486−1.056 0.092
Age (≤ 50/>50) 1.151 0.616−2.152 0.660
Tumor Size (≤ 5/>5 cm) 1.472 0.995−2.179 0.053
Histological Grade (high/low) 2.522 1.663−3.826 <0.001 1.446 0.850−2.460 0.174
LN metastatic (+/−) 4.677 2.697−8.109 <0.001
Nerve invasion (+/−) 2.504 1.632−3.841 <0.001 1.366 0.828−2.252 0.222
Tumor Thrombus (+/−) 2.867 1.824−4.508 <0.001 1.025 0.603−1.743 0.927
pTN (I-III)
I Reference Reference
II 4.809 1.851−12.50 <0.001 3.076 1.103−8.573 0.032
III 15.21 6.113−37.84 <0.001 7.458 2.583−21.54 <0.001
WHO SUBTYPES
Tubular Reference Reference
Mucinous 2.105 1.118−3.965 0.021 0.792 0.398−1.573 0.505
Papillary 2.187 0.990−4.835 0.053 2.464 0.967−6.279 0.059
Poorly cohesive 2.562 1.520−4.318 <0.001 1.023 0.565−1.851 0.940
Undifferentiated 2.051 1.132−3.717 0.018 1.042 0.539−2.016 0.902
Gastrectomy (Palliative/Radical) 6.421 3.695−11.16 <0.001 3.583 1.916−6.701 <0.001
Chemotherapy (+/−) 1.426 0.967−2.104 0.073
TIL (high/low) 0.326 0.212−0.502 <0.001 0.500 0.313−0.797 0.004

Values in bold signify P < 0.05.